As of 2025-03-24, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.08) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -317.2%.
The range of the Relative Valuation is (0.88) - (1.25) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 10.2x | 8.5x |
| Forward P/E multiples | 7.2x - 10.8x | 9.0x |
| Fair Price | (0.88) - (1.25) | (1.08) |
| Upside | -278.7% - -353.2% | -317.2% |
| Date | P/E |